Après délibération, le collège de la Haute Autorité de santé, en sa séance du 17 décembre 2020 a constaté l’absence d’évaluation médico-économique du produit COREVALVE EVOLUT R & EVOLUT PRO sur les dépenses de l’assurance maladie.
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
vcdF0DZX8KLRstT8
